Douglas Kerr

Chief Medical OfficeratDyne Therapeutics· In proxies 2024–2025

Pay in FY2024Dyne Therapeutics stock +77.1% the same year

Douglas Kerr was paid $7.7M in FY2024 (Dec). Dyne Therapeutics stock rose 77.1% that year.

Pay$100 in the stock at the end of FY23 → $177

Pay is from the Summary Compensation Table of each Dyne Therapeutics proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

DYN
Dyne TherapeuticsPublic company · 2 yr
- Chief Medical Officer2024 – Present · 2 yrStock in role +34%

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSV Download PNG How to use our data

Two people shown as one, or a wrong number?